Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1976 Mar;57(3):551–558. doi: 10.1172/JCI108310

Responsiveness to glucagon in fetal hearts. Species variability and apparent disparities between changes in beating, adenylate cyclase activation, and cyclic AMP concentration.

K Wildenthal, D O Allen, J Karlsson, J R Wakeland, C M Clark Jr
PMCID: PMC436687  PMID: 175087

Abstract

Previous studies of the ability of the immature heart to respond to glucagon have yielded conflicting results. To test the possibility that the apparent discrepancies might be explained in part by species variability, isolated hearts of fetal mice and rats (13-22 days' gestational age) were studied under identical conditions in vitro. Changes in atrial rate and ventricular contractility were measured in spontaneously beating hearts exposed to glucagon, and activation of adenylate cyclase was assayed in cardiac homogenates. In mice of 16 days' gestational age or less, there was no change in heart rate in response to glucagon; at 17-18 days, minimal responsiveness was present; and after 19 days, 10muM glucagon caused an increase in spontaneous atrial rate of 30 +/- 4% (SEM) (P less than 0.001). Measurement of the extent and speed of volume displacement of the isotonically contracting hearts with a specially constructed capacitance transducer revealed that ventricular inotropic responsiveness also appeared after 17-19 days. Cardiac stores of glycogen were reduced in older hearts exposed to glucagon, but not in those aged less than 16 days. In contrast, glucagon failed to activate adenylate cyclase in homogenates of hearts of fetal mice at any age. Furthermore, glucagon failed to elicit an increase in the concentration of cyclic AMP in spontaneously beating hearts that developed tachycardia. Responses in hearts of fetal rats were distinctly different from those in mouse hearts: at no age was there any change in heart rate, strength of contraction, glycogen content, or adenylate cyclase activation. Thus, there are major species differences in cardiac pharmacological maturation. Although the mouse heart develops the ability to increase its rate and strength of contraction and to undergo glycogenolysis in response to glucagon well before birth, the rat heart does not. In addition, there is an apparent disparity in late fetal mouse hearts between the ability of glucagon to induce functional responses and its ability to stimulate adenylate cyclase and increase cyclic AMP levels. It is impossible, of course, to rule out absolutely the possibility that localized increases in a critical cyclic AMP pool were present but too small to measure in the entire tissue. Nevertheless, the most obvious interpretation of our results is that they are compatible with the hypothesis that glucagon may exert some of its hemodynamic effects independently from the adenylate cyclase-cyclic AMP system in the late-fetal mouse heart.

Full text

PDF
551

Images in this article

554Image
on p.554

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clark C. M., Jr, Beatty B., Allen D. O. Evidence for delayed development of the glucagon receptor of adenylate cyclase in the fetal and neonatal rat heart. J Clin Invest. 1973 May;52(5):1018–1025. doi: 10.1172/JCI107266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Downing S. E., Talner N. S., Campbell A. G., Halloran K. H., Wax H. B. Influence of sympathetic nerve stimulation on ventricular function in the newborn lamb. Circ Res. 1969 Oct;25(4):417–428. doi: 10.1161/01.res.25.4.417. [DOI] [PubMed] [Google Scholar]
  3. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Glick G. Glucagon. A perspective. Circulation. 1972 Mar;45(3):513–515. doi: 10.1161/01.cir.45.3.513. [DOI] [PubMed] [Google Scholar]
  5. HALL E. K. Acetylcholine and epinephrine effects on the embryonic rat heart. J Cell Physiol. 1957 Apr;49(2):187–200. doi: 10.1002/jcp.1030490203. [DOI] [PubMed] [Google Scholar]
  6. Henry P. D., Dobson J. G., Jr, Sobel B. E. Dissociations between changes in myocardial cyclic adenosine monophosphate and contractility. Circ Res. 1975 Mar;36(3):392–400. doi: 10.1161/01.res.36.3.392. [DOI] [PubMed] [Google Scholar]
  7. Karlsson J. Lactate and phosphagen concentrations in working muscle of man with special reference to oxygen deficit at the onset of work. Acta Physiol Scand Suppl. 1971;358:1–72. [PubMed] [Google Scholar]
  8. Levey G. S., Epstein S. E. Activation of adenyl cyclase by glucagon in cat and human heart. Circ Res. 1969 Feb;24(2):151–156. doi: 10.1161/01.res.24.2.151. [DOI] [PubMed] [Google Scholar]
  9. Levey G. S., Martin S., Levey B. A., Copenhaver W., Ruiz E. 125I-glucagon binding and adenylate cyclase activation in the fetal rat heart. Proc Soc Exp Biol Med. 1974 Jun;146(2):425–431. doi: 10.3181/00379727-146-38119. [DOI] [PubMed] [Google Scholar]
  10. Mayer S. E., Namm D. H., Rice L. Effect of glucagon on cyclic 3',5'-AMP, phosphorylase activity and contractility of heart muscle of the rat. Circ Res. 1970 Feb;26(2):225–233. doi: 10.1161/01.res.26.2.225. [DOI] [PubMed] [Google Scholar]
  11. Murad F., Manganiello V., Vaughan M. A simple, sensitive protein-binding assay for guanosine 3':5'-monophosphate. Proc Natl Acad Sci U S A. 1971 Apr;68(4):736–739. doi: 10.1073/pnas.68.4.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pohl S. L., Birnbaumer L., Rodbell M. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. I. Properties. J Biol Chem. 1971 Mar 25;246(6):1849–1856. [PubMed] [Google Scholar]
  13. Venter H. C., Ross J., Jr, Kaplan N. O. Lack of detectable change in cyclic AMP during the cardiac inotropic response to isoproterenol immobilized on glass beads. Proc Natl Acad Sci U S A. 1975 Mar;72(3):824–828. doi: 10.1073/pnas.72.3.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. White A. A., Zenser T. V. Separation of cyclic 3',5'-nucleoside monophosphates from other nucleotides on aluminum oxide columns. Application to the assay of adenyl cyclase and guanyl cyclase. Anal Biochem. 1971 Jun;41(2):372–396. doi: 10.1016/0003-2697(71)90156-4. [DOI] [PubMed] [Google Scholar]
  15. Wildenthal K., Harrison D. R., Templeton G. H., Reardon W. C. Method for measuring the contractions of small hearts in organ culture. Cardiovasc Res. 1973 Jan;7(1):139–144. doi: 10.1093/cvr/7.1.139. [DOI] [PubMed] [Google Scholar]
  16. Wildenthal K. Maturation of responsiveness to cardioactive drugs. Differential effects of acetylcholine, norepinephrine, theophylline, tyramine, glucagon, and dibutyryl cyclic AMP on atrial rate in hearts of fetal mice. J Clin Invest. 1973 Sep;52(9):2250–2258. doi: 10.1172/JCI107411. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES